Serial Number | 79340816 |
Word Mark | EXSCIENTIA DRIVEN BY KNOWLEDGE |
Filing Date | Monday, March 14, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 9, 2024 |
Registration Number | 7265239 |
Registration Date | Tuesday, January 9, 2024 |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, October 24, 2023 |
Description of Mark | The mark consists of the wording, "EXSCIENTIA" over the wording, "DRIVEN BY KNOWLEDGE. |
Goods and Services | Downloadable computer software for analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics; Downloadable computer software for computer assisted molecule design; Downloadable computer software for chemical and biological research and analysis; Downloadable computer software for pharmaceutical research and development services; Downloadable computer software for diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes for use in the field of molecular research and to combat disease; downloadable computer software for use in the research and development of pharmaceutical products; downloadable computer software for cell analysis; downloadable computer software for the use in managing scientific projects; downloadable computer software for the design of chemical structures; downloadable computer software for the analysis of biological or chemical activity; downloadable artificial intelligence software for healthcare, pharmaceuticals and diagnostics |
Goods and Services | Pharmaceutical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Medical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Veterinary preparations for the treatment of pain, viral diseases, namely, paramyxovirus, influenza A virus, coronavirus, herpes, and hepatitis, wounds, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, mental health disorders, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, cardiovascular diseases and disorders, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, arthritis, inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases, immunologic diseases and disorders, namely Alzheimer's, ulcerative colitis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), allergies, and anxiety; veterinary preparations, namely, vaccines for animals, and sanitary substances for medical use for the treatment of autoimmune diseases, autoimmune diseases, specifically psoriasis, arthritis, and Crohn's disease; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use, food for babies; dietetic substances in the nature of dietetic food adapted for medical or veterinary use; Dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze, bandages; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical, veterinary and sanitary substances and preparations, namely, antifungals, antivirals, herbicides, antibiotics |
Translation of Words in Mark | The English translation of "EXSCIENTIA" in the mark is "FROM KNOWLEDGE". |
Goods and Services | Medical diagnostic testing and medical screening services |
Goods and Services | Scientific and technological services, namely, scientific research, analysis, testing in the field of research and development of pharmaceutical products and molecule design and services relating thereto; industrial analysis and industrial research services in the field of research and development of pharmaceutical products, molecule design and robotics for lab automation and industrial design services; quality control and authentication services in the field of works of scientific research for others; design and development of computer hardware and software; Bioinformatic services, namely, analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics for others; computer assisted molecule design; identification of biological targets, networks and pathways; chemical and biological research and analysis; pharmaceutical research and development services; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes to combat diseases |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 20, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 20, 2022 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 20, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 20, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Exscientia AI Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | GB |
Party Name | Exscientia AI Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | GB |
Party Name | Exscientia AI Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | GB |
Event Date | Event Description |
Thursday, May 19, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, May 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 24, 2022 | APPLICATION FILING RECEIPT MAILED |
Friday, November 4, 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Tuesday, December 27, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Sunday, December 25, 2022 | ASSIGNED TO EXAMINER |
Monday, December 26, 2022 | NON-FINAL ACTION WRITTEN |
Wednesday, February 22, 2023 | REFUSAL PROCESSED BY MPU |
Wednesday, February 22, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, March 15, 2023 | REFUSAL PROCESSED BY IB |
Monday, August 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, August 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, August 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Saturday, September 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 4, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, October 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, October 4, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Tuesday, October 24, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, October 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 24, 2023 | NOTIFICATION PROCESSED BY IB |
Wednesday, October 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, October 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Sunday, November 12, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Tuesday, January 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, January 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, April 10, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, April 10, 2024 | FINAL DISPOSITION PROCESSED |
Monday, April 29, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Saturday, June 1, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, April 9, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |